(Q28216709)
Statements
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts (English)
0 references
1 August 2002
0 references
62
0 references
15
0 references
4263-72
0 references